In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)

Cannabigerol (CBG) and cannabichromene (CBC) are non-psychoactive cannabinoids that have raised increasing interest in recent years. These compounds exhibit good tolerability and low toxicity, representing promising candidates for drug repositioning. To identify novel potential therapeutic targets f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinzi, Luca, Lherbet, Christian, Baltas, Michel, Pellati, Federica, Rastelli, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680637/
https://www.ncbi.nlm.nih.gov/pubmed/31311157
http://dx.doi.org/10.3390/molecules24142567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680637/
https://www.ncbi.nlm.nih.gov/pubmed/31311157
http://dx.doi.org/10.3390/molecules24142567

Ejemplares similares